(73 days)
Not Found
No
The summary describes a digital film processing system for X-ray images with standard image processing capabilities, but there is no mention of AI or ML technologies.
No
The device is described as a "digital film processing system for reading and then digitizing X-ray images." Its function is to process and manage medical images, not to directly treat or diagnose a disease or condition.
No
The device digitizes X-ray images, allowing them to be viewed, stored, post-processed, and printed, but it does not interpret or analyze the images to provide a medical diagnosis.
No
The device description explicitly states that the system consists of "one or more workspots with PCR Eleva Software and one or more image plate readers," and that "The Eleva Workstation consists of a PC, a keyboard, a monitor, and an optional bar-code reader." This indicates the system includes significant hardware components beyond just software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The PCR Eleva System processes and digitizes X-ray images. X-ray imaging is an in vivo (within the living body) diagnostic technique, not an in vitro one.
- Intended Use: The intended use clearly states it's for "reading and then digitizing X-ray images from reusable imaging plates which have been exposed in conventional radiographic examination devices." This describes an imaging workflow, not a laboratory test on biological samples.
- Device Description: The description details the components involved in processing imaging plates and digital X-ray data. There is no mention of handling or analyzing biological samples.
Therefore, the PCR Eleva System falls under the category of medical imaging devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The PCR Eleva System is a digital film processing system for reading and then digitizing X-ray images from reusable imaging plates which have been exposed in conventional radiographic examination devices. The digitized X-ray images can then be viewed, stored, post-processed and printed. The PCR Eleva system can be used in all conventional RAD/RF examination situations, except for mammography. PCR is suitable for routine RAD exams as well as specialist areas, like intensive care units, trauma departments and pediatric departments.
Product codes (comma separated list FDA assigned to the subject device)
LLZ, IXW, LMA
Device Description
A PCR Eleva consists of one or more workspots with PCR Eleva Software and one or more image plate readers. All components are connected via standard ethernet. The system complies with the ACR/NEMA DICOM Version 3 Digital Image Communication in Medicine Standard.
Imaging plates are exposed via conventional X-Ray devices. The imaging plates used in PCR systems are coated with a luminescent material which acts as an x-ray detector. It stores the x-ray image in the form of excited charge carriers. An exposed imaging plate is loaded into the image reader of the PCR Eleva system and the image stored on the imaging plate is scanned with a laser and converted to digital data. The digital X-ray image data is then routed to the Eleva workstation for image processing, viewing, storing and/or printing to film if the workstations are connected to a compatible laser imager. The Eleva Workspot is also used for the scheduling of patients and exams. The Eleva Workstation consists of a PC, a keyboard, a monitor, and an optional bar-code reader.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
X-Ray
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Modifications to the requirements of the predicate device were traced within the design control process and assessed according to the FDA guideline "Deciding When to Submit a 510(k) for a Change to an Existing Device". Verification and validation tests were performed on the complete system relative to the requirement specifications and risk management results, specifically including software verification, validation and DICOM conformance testing. Corresponding test results are included in this submission. All acceptance criteria for a product release according to our product release policy are met.
Based on the test results Philips Medical Systems believes that PCR Eleva 1.2 is at least as safe and effective as the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Philips PCR Eleva 1.2 Special 510(k) Submission
December 21, 2009 Update 01
510(k) Summary
Type of submission: Special 510(k)
Name and Address of manufacturer:
Philips Medical Systems DMC GmbH Röntgenstrasse 24-26 D-22335 Hamburg GERMANY Establishment registration number: 3003768251 Owner/Operator number: 1217116
Submitter:
Philips Medical Systems 22100 Bothell Everett Highway Bothell, WA 98041-3003 Establishment Registration No .: 1217116 Contact: Lynn Harmer 425-487-7312
Device Identification
| 1.2 | Trade Name: | PHILIPS Computed Radiography (PCR) Eleva |
|---|---|---|
| Common names: | Computed Radiography System | |
| Picture Archiving and Communication System | ||
| Product Code: | LLZ | |
| Radiological Image Processing System | ||
| 21CFR 892.2050 | ||
| Subsequent Product Codes: | IXW | |
| Automatic Radiographic Film Processor | ||
| 21CFR 892.1900 | ||
| LMA | ||
| Radiological Image Digitizer | ||
| 21CFR 892.2030 | ||
| Classification: | Class II | |
| Review Panel: | Radiology |
JAN - 8 2010
1
Predicate device:
| Device Name(s): | Philips Computed Radiography (PCR) 5.2 |
|---|---|
| Product Code: | LLZ |
| Regulation Number: | 21CFR 892.2050 |
| Common Product Name: | Automatic Radiographic Film Processor |
| 510(k) Number: | K964124 |
Basis for the Submission
Multiple modifications to PCR 5:2 leading to PCR Eleva Version 1.2
Indications for Use
The PCR Eleva System is a digital film processing system for reading and then digitizing X-ray images from reusable imaging plates which have been exposed in conventional radiographic examination devices. The digitized X-ray images can then be viewed, stored, post-processed and printed. The PCR Eleva system can be used in all conventional RAD/RF examination situations, except for mammography. PCR is suitable for routine RAD exams as well as specialist areas, like intensive care units, trauma departments and pediatric departments.
Description of the System
A PCR Eleva consists of one or more workspots with PCR Eleva Software and one or more image plate readers. All components are connected via standard ethernet. The system complies with the ACR/NEMA DICOM Version 3 Digital Image Communication in Medicine Standard.
Imaging plates are exposed via conventional X-Ray devices. The imaging plates used in PCR systems are coated with a luminescent material which acts as an x-ray detector. It stores the x-ray image in the form of excited charge carriers. An exposed imaging plate is loaded into the image reader of the PCR Eleva system and the image stored on the imaging plate is scanned with a laser and converted to digital data. The digital X-ray image data is then routed to the Eleva workstation for image processing, viewing, storing and/or printing to film if the workstations are connected to a compatible laser imager. The Eleva Workspot is also used for the scheduling of patients and exams. The Eleva Workstation consists of a PC, a keyboard, a monitor, and an optional bar-code reader.
2
Summary and results of nonclinical tests
Modifications to the requirements of the predicate device were traced within the design control process and assessed according to the FDA guideline "Deciding When to Submit a 510(k) for a Change to an Existing Device". Verification and validation tests were performed on the complete system relative to the requirement specifications and risk management results, specifically including software verification, validation and DICOM conformance testing. Corresponding test results are included in this submission. All acceptance criteria for a product release according to our product release policy are met.
Based on the test results Philips Medical Systems believes that PCR Eleva 1.2 is at least as safe and effective as the predicate device.
Conclusion
There have been changes that legally require Philips Medical Systems GmbH to submit a 510(k). This includes a change in the software architecture in order to combine different software applications, and the implementation of a new user interface.
Other modifications are not of such significance that a 510(k) would be required. This includes some improvement of certain functionalities.
None of these modifications lead to a change of the indications for use or alter the fundamental scientific technology or introduce a fundamentally new scientific technology. Therefore it has been concluded that a Special 510(k) is appropriate for this type of submission.
3
Image /page/3/Picture/0 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized eagle with three wavy lines representing the department's mission to promote health, well-being, and human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Ms. Lynn T. Harmer Senior Manager Regulatory Submissions Philips Medical Systems North America Co. 22100 Bothell Everett Highway BOTHELL WA 98021-8431
Re: K093355
Trade/Device Name: PHILIPS Computed Radiography (PCR) Eleva 1.2 Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: December 21, 2009 Received: December 23, 2009
JAN - 8 2010
Dear Ms. Harmer:
/
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (teporting of medical
4
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803); please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.html
Sincerely yours,
Janine M. Morris
Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Philips PCR Eleva 1.2 Special 510(k) Submission
October 16, 2009
Indications for Use
510(k) Number (if known): 《G3355
Device Name: PHILIPS Computed Radiography (PCR) Eleva 1.2
Indications For Use:
The PCR Eleva System is a digital film processing system for reading and then digitizing X-ray images from reusable imaging plates which have been exposed in conventional radiographic examination devices. The digitized X-ray images can then be viewed, stored, post-processed and printed. The PCR Eleva system can be used in all conventional RAD/RF examination situations, except for mammography. PCR is suitable for routine RAD exams as well as specialist areas, like intensive care units, trauma departments and pediatric departments.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IFNEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Huber Reum
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Deviçe 093255 510(k) Number
Page 1 of
1